Abstract:Background. Spinal cord injury (SCI) is one of the serious neurological diseases that occur in young people with high morbidity and disability. However, there is still a lack of effective treatments for it. Stem cell (SC) treatment of SCI has gradually become a new research hotspot over the past decades. This article is aimed at reviewing the research progress of SC therapy for SCI. Methods. Review the literature and summarize the effects, strategies, related mechanisms, safety, and clinical application of different SC types and new approaches in combination with SC in SCI treatment. Results. A large number of studies have focused on SC therapy for SCI, most of which showed good effects. The common SC types for SCI treatment include mesenchymal stem cells (MSCs), hematopoietic stem cells (HSCs), neural stem cells (NSCs), induced pluripotent stem cells (iPSCs), and embryonic stem cells (ESCs). The modes of treatment include in vivo and in vitro induction. The pathways of transplantation consist of intravenous, transarterial, nasal, intraperitoneal, intrathecal, and intramedullary injections. Most of the SC treatments for SCI use a number of cells ranging from tens of thousands to millions. Early or late SC administration, application of immunosuppressant or not are still controversies. Potential mechanisms of SC therapy include tissue repair and replacement, neurotrophy, and regeneration and promotion of angiogenesis, antiapoptosis, and anti-inflammatory. Common safety issues include thrombosis and embolism, tumorigenicity and instability, infection, high fever, and even death. Recently, some new approaches, such as the pharmacological activation of endogenous SCs, biomaterials, 3D print, and optogenetics, have been also developed, which greatly improved the application of SC therapy for SCI. Conclusion. Most studies support the effects of SC therapy on SCI, while a few studies do not. The cell types, mechanisms, and strategies of SC therapy for SCI are very different among studies. In addition, the safety cannot be ignored, and more clinical trials are required. The application of new technology will promote SC therapy of SCI.

Stem Cell Therapies for Central Nervous System Trauma: The 4 Ws—What, When, Where, and Why

Stem Cells: Current Approach and Future Prospects in Spinal Cord Injury Repair

Stem Cells in Central Nervous System Diseases: Promising Therapeutic Strategies.

Stem Cells for the Treatment of Neurodegenerative Diseases

The Potential of Stem Cells in Treatment of Traumatic Brain Injury

Stem Cell Transplantation: A Promising Therapy for Spinal Cord Injury.

New Insights into the Biological Roles of Immune Cells in Neural Stem Cells in Post-Traumatic Injury of the Central Nervous System

Stem Cell Therapy: A Promising Therapeutic Method for Intracerebral Hemorrhage.

Advance of Stem Cell Treatment for Traumatic Brain Injury

The Application of Neural Stem/Progenitor Cells for Regenerative Therapy of Spinal Cord Injury

Stem Cell Therapy for Spinal Cord Injury

The Current Update of Conventional and Innovative Treatment Strategies for Central Nervous System Injury

Mesenchymal Stromal Cell Therapies for Traumatic Neurological Injuries

A Brief Summary of Current Therapeutic Strategies for Spinal Cord Injury

Safety of Neural Stem Cell Transplantation in Patients with Severe Traumatic Brain Injury.

Stem Cell Therapies for Restorative Treatments of Central Nervous System Ischemia–Reperfusion Injury

Progenitor Cell Therapy for the Treatment of Central Nervous System Injury: A Review of the State of Current Clinical Trials

Progress in Stem Cell Therapy for Spinal Cord Injury

Stem cell-based therapies to treat spinal cord injury: a review

Advances in Neural Stem Cell Therapy for Spinal Cord Injury: Safety, Efficacy, and Future Perspectives

Non-stem cell-derived exosomes: a novel therapeutics for neurotrauma